Pheast Therapeutics

Redwood City, CA · Founded 2021 · Privately Held (backing)

Provider of immuno-oncology therapies intended to activate the innate immune system to fight cancer. Pheast Therapeutics is based in Redwood City, CA and was founded in 2021. It was valued at $155 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $101 million across 2 recorded rounds; the latest was a $24.6 million early-stage round in Oct 2025.

PMV mark · valuation
$154.6M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$100.6M
Last round
Early Stage VC
Oct 2025
How much has Pheast Therapeutics raised?
$100.6Macross 2 recorded rounds · Jan 2022 – Oct 2025

Most recently, Pheast Therapeutics raised $24.6M in its Early Stage VC (Oct 2025).

Free account
More of Pheast Therapeutics with a free account
  • ·Watch Pheast Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Pheast Therapeutics round by round

2 rounds
Oct 2025Early Stage VC$24.6MSEC filing▮
7 investors participated
Jan 2022Later Stage VC$75.3MSEC filing▮
7 investors participated

How much has Pheast Therapeutics raised?

Pheast Therapeutics has raised $101 million across 2 recorded rounds since 2022. The largest was a $75.3 million later-stage round in Jan 2022; the most recent was a $24.6 million early-stage round in Oct 2025.

Pheast Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Apr 2025 ($75.3 million sold to 7 investors).

Pheast Therapeutics investors

4 investors are on record for Pheast Therapeutics, including Alexandria Venture Investments, ARCH Venture Partners, Catalio Capital Management and Rsquared. The early-stage round in Oct 2025 drew 7 investors.

For fundraisers
Raising for a company like Pheast Therapeutics?

4 investors have backed Pheast Therapeutics.

See all 4 investors →

Frequently asked about Pheast Therapeutics

How much has Pheast Therapeutics raised?
Pheast Therapeutics has raised $100.6M in total across 2 recorded funding rounds.
When was Pheast Therapeutics's last funding round?
Pheast Therapeutics's most recent recorded round was Early Stage VC in Oct 2025, raising $24.6M.